Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Chung-Hwan Chen, Abdulaziz H. Elsalmawy, Sophia Ish-Shalom, Seung-Jae Lim, Nadia S. Al-Ali, Joao L. Cunha-Borges, Huilin Yang, Noemí Casas, Lale Altan, Thomas Moll, Sirel Gurbuz, Alan J.M. Brnabic, Russel T. Burge & Fernando Marin. (2019) Study description and baseline characteristics of the population enrolled in a multinational, observational study of teriparatide in postmenopausal women with osteoporosis: the Asia and Latin America Fracture Observational Study (ALAFOS). Current Medical Research and Opinion 35:6, pages 1041-1049.
Read now
Read now
Atsushi Nishikawa, Takehiro Ishida, Masanori Taketsuna, Fumito Yoshiki & Hiroyuki Enomoto. (2016) Safety and effectiveness of daily teriparatide in a prospective observational study in patients with osteoporosis at high risk of fracture in Japan: final report. Clinical Interventions in Aging 11, pages 913-925.
Read now
Read now
Articles from other publishers (11)
Georgios Kontogeorgos, Emily Krantz, Penelope Trimpou, Christine M. Laine & Kerstin Landin-Wilhelmsen. (2022) Teriparatide treatment in severe osteoporosis – a controlled 10-year follow-up study. BMC Musculoskeletal Disorders 23:1.
Crossref
Crossref
Tomaz Kocjan, Antonela Sabati Rajic, Mojca Jensterle Sever, Andrej Janez, Gaj Vidmar, Nina Orehek, Janja Marc & Barbara Ostanek. (2021) Treatment of osteoporosis with teriparatide: The Slovenian experience. Open Medicine 16:1, pages 1544-1551.
Crossref
Crossref
Barbara Hauser, Nerea Alonso & Philip L Riches. (2021) Review of Current Real-World Experience with Teriparatide as Treatment of Osteoporosis in Different Patient Groups. Journal of Clinical Medicine 10:7, pages 1403.
Crossref
Crossref
Joao L. Cunha-Borges, Guillermo Meléndez Mier, Noemí Casas, Adriana Medina, Jose Fernando Molina, Maria Laura García, Lindomar Guimarães Oliveria, Marcela S. Caselato, Angélica C. Cruz, Vanessa Ippolito & Sandra Flórez. (2019) Baseline characteristics of postmenopausal women with osteoporosis treated with teriparatide in a real-world setting in Latin America: a subregional analysis from the Asia and Latin America Fracture Observational Study (ALAFOS). Advances in Rheumatology 59:1.
Crossref
Crossref
Stuart Silverman, Bente L. Langdahl, Saeko Fujiwara, Ken Saag, Nicola Napoli, Satoshi Soen, Hiroyuki Enomoto, Thomas E. Melby, Damon P. Disch, Fernando Marin & John H. Krege. (2018) Reduction of Hip and Other Fractures in Patients Receiving Teriparatide in Real-World Clinical Practice: Integrated Analysis of Four Prospective Observational Studies. Calcified Tissue International 104:2, pages 193-200.
Crossref
Crossref
Kyriakos Aloumanis, G. Kapetanos, T. Alexandridis, V. Drossinos & N. Papaioannou. (2018) Conducting an observational study during an economic crisis: analysis of the treatment and follow-up phase of Greek patients participating in the ExFOS study. Hormones 17:4, pages 531-540.
Crossref
Crossref
Nicola Napoli, Bente. L. Langdahl, Östen Ljunggren, Eric Lespessailles, George Kapetanos, Tomaz Kocjan, Tatjana Nikolic, Pia Eiken, Helmut Petto, Thomas Moll, Erik Lindh & Fernando Marin. (2018) Effects of Teriparatide in Patients with Osteoporosis in Clinical Practice: 42-Month Results During and After Discontinuation of Treatment from the European Extended Forsteo® Observational Study (ExFOS). Calcified Tissue International 103:4, pages 359-371.
Crossref
Crossref
Bente L. Langdahl, Östen Ljunggren, Claude-Laurent Benhamou, Fernando Marin, George Kapetanos, Tomaz Kocjan, Eric Lespessailles, Nicola Napoli, Tatjana Nikolic, Helmut Petto, Thomas Moll & Erik Lindh. (2016) Fracture Rate, Quality of Life and Back Pain in Patients with Osteoporosis Treated with Teriparatide: 24-Month Results from the Extended Forsteo Observational Study (ExFOS). Calcified Tissue International 99:3, pages 259-271.
Crossref
Crossref
Kyriakos Aloumanis, George Kapetanos, Nikolaos Bartzis & Vangelis Drossinos. (2015) Teriparatide use during an economic crisis: baseline data from the Greek cohort of the Extended Forsteo Observational Study (ExFOS). BMC Musculoskeletal Disorders 16:1.
Crossref
Crossref
Anne-Luise Thorsteinsson, Peter Vestergaard & Pia Eiken. (2015) Compliance and persistence with treatment with parathyroid hormone for osteoporosis. A Danish national register-based cohort study. Archives of Osteoporosis 10:1.
Crossref
Crossref
Antimo Moretti, Francesca Gimigliano, Gioconda Di Pietro, Raffaele Gimigliano & Giovanni Iolascon. (2015) Back pain-related disability and quality of life in patients affected by vertebral fractures: data from baseline characteristics of population enrolled in Denosumab In Real Practice (DIRP). Aging Clinical and Experimental Research 27:S1, pages 3-9.
Crossref
Crossref